Cat. #151075
Anti-EpCAM [AUA1]
Cat. #: 151075
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: Epithelial Cell Adhesion Molecule (EpCAM, CD326)
Class: Monoclonal
Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Walter Bodmer
Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-EpCAM [AUA1]
- Research fields: Cancer;Cell biology
- Clone: AUA1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 40 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
- Description: AUA1 cross reacts with breast carcinomas, kidney tubules, tonsil crypt epithelium and cells in some serious effusions. This is a good antibody for characterisation of all epithelial cells.
- Immunogen: LoVo cell line, a colon carcinoma cell line.
- Immunogen uniprot id: P04216
- Isotype: IgG1
- Myeloma used: P3X63Ag8
Target Details
- Target: Epithelial Cell Adhesion Molecule (EpCAM, CD326)
- Molecular weight: 40 kDa
- Target background: AUA1 cross reacts with breast carcinomas, kidney tubules, tonsil crypt epithelium and cells in some serious effusions. This is a good antibody for characterisation of all epithelial cells.
Applications
- Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 0.93mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
Related Tools
- Related tools: Anti-EpCAM, Recombinant [AUA1]
References
- Hsia et al. 2016. Proc Natl Acad Sci U S A. :. PMID: 27036009.
- Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers.
- Screening of carcinoma metastasis by flow cytometry: A study of 238 cases.
- Acosta et al. 2015. Cytometry B Clin Cytom. :. PMID: 26054018.
- Yeung et al. 2013. Br J Cancer. 108(10):2106-15. PMID: 23652304.
- Myofibroblast activation in colorectal cancer lymph node metastases.
- Yeung et al. 2010. Proc Natl Acad Sci U S A. 107(8):3722-7. PMID: 20133591.
- Cancer stem cells from colorectal cancer-derived cell lines.
- Gaster et al. 2009. Nat Med. 15(11):1327-32. PMID: 19820717.
- Matrix-insensitive protein assays push the limits of biosensors in medicine.
- Ntouroupi et al. 2008. Br J Cancer. 99(5):789-95. PMID: 18682708.
- Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope.
- Shaw et al. 2008. Cancer Cell Int. 8:3. PMID: 18348720.
- Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling.
- Moss et al. 1988. Lung Cancer. 4, 76-78.
- Epenetos et al. 1982. Lancet. 2(8306):1004-6. PMID: 6127499.
- Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
- Epenetos et al. 1982. Br J Cancer. 46(1):1-8. PMID: 7104190.
- Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodies.
